4 Ways Sullivan & Cromwell Can Talk Up Valeant's Salix Bid

By Benjamin Horney (March 12, 2015, 6:09 PM EDT) -- Less than a year after losing a very public battle to buy drugmaker Allergan Inc. in which it played the role of hostile bidder, Valeant Pharmaceuticals International Inc. has found itself in yet another big-money takeover duel as it attempts to pick up gastrointestinal treatment developer Salix Pharmaceuticals Ltd....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!